March 31-April 2, 2015
Shangri-La Pudong Hotel – Shanghai, China
“Healthcare ROI by 2020: Betting on China or US?”
PROGRAM AGENDA & SCHEDULE OF EVENTS
DAY ONE: TUESDAY, MARCH 31, 2015
12:30 pm – 4:30 pm
Pre-Conference & Boot Camp Registration
ENTREPRENEUR BOOT CAMP
1:00 pm – 1:05 pm
Opening Remarks
Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati
Kewen Jin, Chairman, BayHelix
1:05 pm – 2:00 pm
Creatively Seeking Funding Sources for Your Diagnostic, Drug, Medical
Device and E-health Companies
Moderator: Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati
Sabrina Li, CEO, Coyote Biosciences
Peter Luo, Founder & CEO, Adagene
Fay Xing, Principal, Decheng Venture
Francine Fang, Venture Partner, Fidelity Growth Partners Asia
2:00 pm – 2:30 pm
“IP Strategy” - Getting Ready for Funding Pitch and Beyond
Moderator: Yuwen Liu, Executive Director, BioBAY
Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati
Kang Ying, CEO, AccuraGen
Alex Chen, CEO, Crystal Pharmatech
Lifang Sun, IP, Luye Pharmaceutical
2:30 pm – 2:45 pm
Coffee Break
2:45 pm – 3:45 pm
Current Market Conditions for IPO and What Are the Challenges in
Investment Exit Through Capital Markets
Moderator: Ethan Jin, Partner, Wilson Sonsini Goodrich & Rosati
Bruce Ge, Managing Partner, GLB Capital
Liwei Jiang, CEO, PW Meditech Group (invited)
3:45 pm – 4:00 pm
Q&A
4:00 pm – 5:30 pm
Emerging Company Showcase
Moderator: Kewen Jin, Chairman, BayHelix
Peng Wang, GM, Yabao Pharmaceuticals
Marietta Wu, COO, Zai Laboratory
Jun Bao, SVP & Chief Business Officer, Shenogen
Nick Zhang, GM, Qiagen Translational Medicine
Shu Jen Chen, CSO, ACT Genomics
Tsang-Bing Tzeng, CEO, TAP
Ming Kuang, GM, Portable Diabetes Management Platform
5:30 pm – 7:00 pm
WSGR BayHelix Welcome Cocktail Reception
DAY TWO: WEDNESDAY, APRIL 1, 2015
7:15 am – 8:15 am
Registration
8:00 am – 8:15 am
Introductory Remarks
8:15 am – 8:45 am
Technology Innovation and Global Collaboration in China
Pharmaceutical Industry
Guowei Sang, Ex-Vice Chairman of Standing Committee of National
People’s Congress (invited)
8:45 am – 9:15 am
Current Development status and challenges in China Pharmaceutical
Industry
Hongren Zhu, Chief Engineer, Ministry of Industry and Information
Technology (invited)
9:15 am – 9:45 am
Supervisory Policy and Development Status of China’s Biosimilar
Maozhong Li, vice Director, Dept. of Drug and Cosmetics Registration,
SFDA (invited)
9:45 am – 10:15 am
The Strategic Positioning for Chinese Companies in the Global Market
Dianbo Liu, Executive Chairman, Luye Pharmaceutical
10:15 am – 10:45 am
How Chinese Companies Can Face the World
Tsu-Der Lee, Chairman, SwissRay Group
10:45 am – 11:15 am
The Paradigm Shift of China Healthcare Market Value Chain
Richard Yeh, Head of China Healthcare Research, Citi Research
11:15 am – 12:15 pm
Panel Discussion: Innovation in China
Ruilin Song, Chairman, Sino PHIRDA
Chinese Academy of Sciences (invited)
Samantha Du, CEO, Zai Laboratory
Steve Yang, EVP & COO, WuXi AppTec
12:15 pm – 1:30 pm
Lunch & Networking
TRACK ONE: PHARMACEUTICALS & BIOTECH
Session Chairs:
Jasmine Luo, VP & CIO, China Health Industry Capital Fund Management
Marietta Wu, COO, Zai Laboratory
1:30 pm – 2:00 pm
The State of US Biotech
David Flores, President & CEO, BioCentury
2:00 pm – 3:00 pm
Panel Discussion: Biosimilar and Biologics Drug Development in China
Aradhana Sarin, Managing Director, Global Healthcare, Citi
Chris Chen, SVP & CTO, Biologics Services, WuXi AppTec
Michael Yu, President & CEO, Innovent Biologics
Zhenping Zhu, EVP, Kadmon Corporation
Daotian Fu, General Manager, Livzon Mabpharm
3:00 pm – 6:00 pm
Company Presentations & Discussion
Yinxiang Wang, CEO, Betta Pharmaceuticals (invited)
Friedhelm Blobel, CEO, SciClone Pharmaceuticals
Wren Zhang, CEO & President, GC-Rise Health Science
Michael Yu, President & CEO, Innovent Biologics
John Oyler, Founder & CEO, Beigene
Ting Xu, CEO & President, Alphamab
Racho Jordanov, Co-Founder, President & CEO, JHL Biotech
6:00 pm – 6:15 pm
Closing Remarks
6:15 pm – 7:00 pm
Cocktail Reception
7:00 pm – 8:30 pm
Conference Gala Dinner Hosted by Citi
TRACK TWO: HEALTHCARE SERVICES
Session Chair:
Norman Chen, Venture Partner, Fidelity Growth Partners Asia
1:30 pm – 2:00 pm
Opportunities and Challenges of Operating Private Hospitals in Asia
See Leng Tan, Managing Director & CEO, IHH Healthcare Berhad
2:00 pm – 5:15 pm
Company Presentations & Discussion
Adam Sun, Chief Investment Officer, Concord
United Family (invited)
Tim Guo, Director of Medical Affairs, DeltaHealth
Phoenix (invited)
Jacqueline Mei, General Manager of Strategic Planning, Fosun Pharma
Shijun Wu, Aier Ophthalmology
5:15 pm – 6:00 pm
Panel Discussion: Private Hospitals in China- More Risks or More
Rewards?
Moderator: Norman Chen, Venture Partner, Fidelity Growth Partners Asia
Jiadi Yu, Senior Investment Officer, IFC
Adam Sun, Chief Investment Officer, Concord
Tim Guo, Director of Medical Affairs, DeltaHealth
Jacqueline Mei, General Manager of Strategic Planning, Fosun Pharma
Shijun Wu, Aier Ophthalmology
6:00 pm – 6:15 pm
Closing Remarks
6:15 pm – 7:00 pm
Cocktail Reception
7:00 pm – 8:30 pm
Conference Gala Dinner Hosted by Citi
DAY THREE: THURSDAY, APRIL 2, 2015
7:45 am – 8:15 am
Registration
8:15 am – 8:30 am
Introductory Remarks
8:30 am – 9:00 am
Medical Associations - A Catalyst for Change
Henry Solomon, Senior Medical Advisor, American College of Cardiology
9:00 am – 9:30 am
The Strategic Positioning and Roadmap for the Chinese Market for a
Multinational Company
Vladimir Makatsaria, Company Group Chairman, J&J Asia Pacific
9:30 am – 10:30 am
Panel Discussion: MNC’s vs Local Companies: The Dynamic of
Competition in China
Moderator: Chen Yu, Managing Partner, Vivo Capital
Libo Yang, Founder, Bass Medical Group
Jay Qin, Chairman, Shanghai Kinetic
Noam Krantz, Vice President, New Business Development, Ethicon
Lifei Cheng, Head, Strategy, BD & Ventures, Medtronic
Tsu-Der Lee, Chairman, SwissRay Group
10:30 am – 12:00 pm
Panel Discussion: Private Equity Investment: What’s HOT in China?
Moderator: Frank F.C. Kung, Senior Managing Partner/CEO & Chairman,
Vivo Capital
VC Panelists:
Jonathan Wang, Senior Managing Director, OrbiMed
Rebecca Lin, Partner & Chief Representative, Fidelity Growth Partners Asia
Jasmine Luo, VP & CIO, China Health Industry Capital Fund Management
James Hsu, Managing Director, CDIB Healthcare Fun
Albert Cha, Managing Partner, Vivo Capital
PE Panelists:
Dong Liu, Managing Director, CITICPE
Michael Yi, Co-Founder & Managing Partner, Hillhouse
Chris Sweeney, Partner, Water Street Healthcare Partners
12:00 pm – 1:15 pm
Lunch and Networking
TRACK THREE: MEDTECH (DEVICES, INSTRUMENTS, DIAGNOSTICS)
Session Chair:
Chen Yu, Managing Partner, Vivo Capital
1:30 pm – 2:00 pm
A Multinational’s China Strategy
Christopher Cleary, VP, Corporate Development, Medtronic
2:00 pm – 4:30 pm
Company Presentations & Discussion
Victor Chao, GM, Golden Stapler Surgical
Mike Zhu, Executive VP, Amoy Diagnostics
Jianqing Yao, CEO, Shanghai Ketai Medical Device
Guanghui Hu, President, Admera
Jay Qin, Chairman, Shanghai Kinetic
Hong Tan, CEO, ET Healthcare
Pan Zheng, CEO, MicroTech Medical
Vivi Long, VP & CFO, Apex Medical
Yihua Ning, SceneRay
4:30 pm – 5:30 pm
NGS: How Could Genomics Change the Landscape of Disease
Prevention and Treatment?
David Wang, Senior Managing Director, OrbiMed
Edward Hu, CFO & CIO, WuXi AppTec
Victor Shi, President, Asia-Pacific, Qiagen (invited)
5:30 pm
Conference Concludes
5:30 pm – 8:00 pm
Innovation Night at Boston Scientific Innovation Center
TRACK FOUR: EHEALTHCARE
Session Chairs:
James Li, VP & GM, Greater China, Amgen
Cyber Cao, Principal, Vivo Capital
1:30 pm – 2:00 pm
An Overview of US eHealth Market Dynamics and Business Models
Steven Yecies, Venture Partner, OrbiMed
2:00 pm – 2:30 pm
Emerging Force of Chinese eHealth
Franck Le Deu, Partner, McKinsey & Company
2:30 pm – 4:30 pm
Company Presentations and Discussion
Li Ma, VP of Strategy, AliHealth
Rui Zhang, CEO, Spring Rain
Junhai Wang, Co-Founder, Zhang Shang Yao Dian
Bo Liu, CEO, Huakang Mobile Health
J1.com
John Zhang, CEO, E-Techco Information Technologies
Weining Software
4:30 pm – 5:30 pm
Panel Discussion: Healthcare IT/mHealth
Steven Yecies, Venture Partner, OrbiMed
Li Ma, VP of Strategy, AliHealth
Wenxin Yu, Equity Research Analyst (Chief of Healthcare Sector), Haitong
Securities
Jiang Zhang, GM, Ping An Ventures
Yiqin Yin, Head of IT, Zhongshan Hospital
5:30 pm
Conference Concludes
5:30 pm – 8:00 pm
Innovation Night at Boston Scientific Innovation Center